Synthesis of the novel mannosidase inhibitors (3R)- and (3S)-3-(hydroxymethyl)swainsonine
β Scribed by Erik J. Hembre; William H. Pearson
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- French
- Weight
- 805 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0040-4020
No coin nor oath required. For personal study only.
β¦ Synopsis
Swainsonine ( ) is an important mannosidase inhibitor that has been examined clinically as an anticancer drug. The preparation of analogs of swainsonine bearing a hydroxymethyl group at C(3), i.e., (3R)-3-(hydroxymethyl)swainsonine [( ), (3R)-HMS] and (3S)-3-(hydroxymethyl)swainsonine [( ), (3S)-HMS] is described. The synthesis of each analog begins with D-ribose, and involves a Claisen rearrangement, a Sharpless osmylation, and a reductive double-cyclization of either an azido mesylate bearing a lactone (i.e. 24 =:~ 11) or an azido epoxide beating a lactone (i.e. 27 ~ 10). Both (3R)-HMS and (3S)-HMS were found to be effective inhibitors of ot-mannosidase from jack bean.
π SIMILAR VOLUMES
Swainsonine (3), an inhibitor of Golgi a-mannosidase II, is a clinical candidate for cancer treatment. In order to avoid potential problems arising from its co-inhibition of lysosomal mannosidases, we have synthesized 3-benzyloxymethyl analogs of swainsonine (17 and 18). Initial screening of these n
CH 2 Cl 2 , -45 ΛC Zr(O t Bu) 4 (10 mol%) (R)-6,6'-Br 2 BINOL (22 mol%) N-methylimidazole (12 mol%) 2 3 MS4A (250 mg/mmol) R = Bn(3a) 39% yield, 54% ee. R = TBDPS(3b) 71% yield, 16% ee. R = TBS(3c) 47% yield, 80% ee.
The synthesis of 46 derivatives of (2R,3R,4S)-2-(aminomethyl)pyrrolidine-3,4-diol is reported (Scheme 1 and Fig. 3), and their inhibitory activities toward a-mannosidases from jack bean (B) and almonds (A) are evaluated (Table ). The most-potent inhibitors are (2R,3R,4S)-2-{[([1,1'-biphenyl]-4-ylmet